StockNews.com downgraded shares of Koninklijke Philips (NYSE:PHG – Free Report) from a buy rating to a hold rating in a research note published on Thursday.
Separately, Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.
View Our Latest Research Report on Koninklijke Philips
Koninklijke Philips Stock Up 0.4 %
Institutional Trading of Koninklijke Philips
Institutional investors have recently made changes to their positions in the business. XTX Topco Ltd increased its stake in Koninklijke Philips by 73.0% during the 3rd quarter. XTX Topco Ltd now owns 30,726 shares of the technology company’s stock valued at $1,005,000 after purchasing an additional 12,969 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of Koninklijke Philips during the third quarter worth about $205,000. Jane Street Group LLC boosted its position in Koninklijke Philips by 787.9% in the third quarter. Jane Street Group LLC now owns 128,686 shares of the technology company’s stock valued at $4,211,000 after buying an additional 114,193 shares during the last quarter. Kovitz Investment Group Partners LLC increased its holdings in Koninklijke Philips by 4.7% in the 3rd quarter. Kovitz Investment Group Partners LLC now owns 76,186 shares of the technology company’s stock worth $2,462,000 after buying an additional 3,418 shares during the period. Finally, State Street Corp raised its position in Koninklijke Philips by 1.0% during the 3rd quarter. State Street Corp now owns 82,518 shares of the technology company’s stock worth $2,809,000 after buying an additional 844 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- There Are Different Types of Stock To Invest In
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What to Know About Investing in Penny Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.